跳至主要内容
临床试验/NCT04290351
NCT04290351已完成不适用

Comparative Study of Band Ligation and Phlebotonic Drug Versus Only Phlebotonic Drug, in Bleeding Internal Hemorrhoids.

Konya Meram State Hospital1 个研究点 分布在 1 个国家目标入组 69 人开始时间: 2020年11月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
69
试验地点
1
主要终点
Hemorrhage stopped on the day of treatment.

研究概览

简要总结

In this study, the researchers planned to compare the treatment results of patients undergoing rubber band ligation in addition to drug therapy in hemorrhagic internal hemorrhoids patients and those treated only with anti-hemorrhoidal drugs.

详细描述

Introduction: Band ligation is one of the most frequently used methods in the treatment of hemorrhagic internal hemorrhoidal disease. Also, phlebotonic use and surgical excision options are available as an anti-hemorrhoidal drug in the treatment of the disease. Many studies have shown that these methods are safe to use. Band ligation is used quite often in our clinic. Whether or not band ligation is performed, these patients are prescribed phlebotonics as an anti-hemorrhoidal drug.

Purpose: In this study, investigators aimed to investigate the benefit of adding rubber band ligation to treatment in hemorrhagic internal hemorrhoidal disease treated with the anti hemorrhoidal drug.

Method: The study was planned prospectively and observationally. Patients are not assigned to groups by the researcher. The researcher cannot interfere with the treatment method given to the patient. The method of treatment is the method approved by the patient's doctor.

Patients diagnosed with internal hemorrhoids will be examined in a group of patients who are prescribed anti-hemorrhoidal drugs and rubber band ligation in the context of routine treatment.

In the other group, again, in the form of routine treatment, patients who are not given rubber band ligation and who are given only anti-hemorrhoidal drugs will be examined.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with internal hemorrhoids with an anamnesis + examination + rectoscope.

排除标准

  • Patients under 18 years old
  • Patients over 65 years old
  • Chronic liver patients
  • Those with bleeding disorders
  • Patients taking anti-coagulants and anti-aggregates
  • Patients with colorectal cancer.
  • Those who have had hemorrhoid surgery before

研究组 & 干预措施

Band ligation and phlebotonic group

Patients with rubber band ligation and the prescribed anti hemorrhoidal drug will be examined in this group.

(Note: The researcher has no contribution or intervention to the treatment method.)

干预措施: band ligation (Procedure)

Band ligation and phlebotonic group

Patients with rubber band ligation and the prescribed anti hemorrhoidal drug will be examined in this group.

(Note: The researcher has no contribution or intervention to the treatment method.)

干预措施: oral 450 mg diosmin+50 mg hesperidin (Drug)

Only phlebotonic group

Patients who are prescribed the only 450mg of diosmin + 50mg of hesperidin as a treatment for bleeding internal hemorrhoids will be examined in this group.

(Note: The researcher has no contribution or intervention to the treatment method.)

干预措施: oral 450 mg diosmin+50 mg hesperidin (Drug)

结局指标

主要结局

Hemorrhage stopped on the day of treatment.

时间窗: 21 days

It will be determined that the bleeding stops on the day of treatment.

hemostasis rate

时间窗: 21 days

At the end of the treatment, the proportion of patients without hemorrhoids bleeding will be calculated.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alpaslan Şahin

principal investigators

Konya Meram State Hospital

研究点 (1)

Loading locations...

相似试验